Literature DB >> 24442434

NFIL3-deficient mice develop microbiota-dependent, IL-12/23-driven spontaneous colitis.

Taku Kobayashi1, Erin C Steinbach, Steven M Russo, Katsuyoshi Matsuoka, Tomonori Nochi, Nitsan Maharshak, Luke B Borst, Bruce Hostager, J Victor Garcia-Martinez, Paul B Rothman, Masaki Kashiwada, Shehzad Z Sheikh, Peter J Murray, Scott E Plevy.   

Abstract

NFIL3 is a transcription factor that regulates multiple immunologic functions. In myeloid cells, NFIL3 is IL-10 inducible and has a key role as a repressor of IL-12p40 transcription. NFIL3 is a susceptibility gene for the human inflammatory bowel diseases. In this article, we describe spontaneous colitis in Nfil3(-/-) mice. Mice lacking both Nfil3 and Il10 had severe early-onset colitis, suggesting that NFIL3 and IL-10 independently regulate mucosal homeostasis. Lymphocytes were necessary for colitis, because Nfil3/Rag1 double-knockout mice were protected from disease. However, Nfil3/Rag1 double-knockout mice adoptively transferred with wild-type CD4(+) T cells developed severe colitis compared with Rag1(-/-) recipients, suggesting that colitis was linked to defects in innate immune cells. Colitis was abrogated in Nfil3/Il12b double-deficient mice, identifying Il12b dysregulation as a central pathogenic event. Finally, germ-free Nfil3(-/-) mice do not develop colonic inflammation. Thus, NFIL3 is a microbiota-dependent, IL-10-independent regulator of mucosal homeostasis via IL-12p40.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24442434      PMCID: PMC3948213          DOI: 10.4049/jimmunol.1301819

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

Review 1.  The genetics of inflammatory bowel disease.

Authors:  Judy H Cho; Casey T Weaver
Journal:  Gastroenterology       Date:  2007-10       Impact factor: 22.682

Review 2.  Unravelling the pathogenesis of inflammatory bowel disease.

Authors:  R J Xavier; D K Podolsky
Journal:  Nature       Date:  2007-07-26       Impact factor: 49.962

3.  Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses.

Authors:  Timothy L Denning; Yi-chong Wang; Seema R Patel; Ifor R Williams; Bali Pulendran
Journal:  Nat Immunol       Date:  2007-09-16       Impact factor: 25.606

4.  Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells.

Authors:  Anja Fuchs; William Vermi; Jacob S Lee; Silvia Lonardi; Susan Gilfillan; Rodney D Newberry; Marina Cella; Marco Colonna
Journal:  Immunity       Date:  2013-02-28       Impact factor: 31.745

5.  Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.

Authors:  Naoko Satoh-Takayama; Christian A J Vosshenrich; Sarah Lesjean-Pottier; Shinichiro Sawa; Matthias Lochner; Frederique Rattis; Jean-Jacques Mention; Kader Thiam; Nadine Cerf-Bensussan; Ofer Mandelboim; Gerard Eberl; James P Di Santo
Journal:  Immunity       Date:  2008-12-11       Impact factor: 31.745

6.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Sean Stevens; Richard A Flavell
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

7.  Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis.

Authors:  Nobuhiko Kamada; Tadakazu Hisamatsu; Susumu Okamoto; Hiroshi Chinen; Taku Kobayashi; Toshiro Sato; Atsushi Sakuraba; Mina T Kitazume; Akira Sugita; Kazutaka Koganei; Kiyoko S Akagawa; Toshifumi Hibi
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

8.  IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.

Authors:  T Kobayashi; S Okamoto; T Hisamatsu; N Kamada; H Chinen; R Saito; M T Kitazume; A Nakazawa; A Sugita; K Koganei; K Isobe; T Hibi
Journal:  Gut       Date:  2008-07-24       Impact factor: 23.059

9.  RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells.

Authors:  Stephanie L Sanos; Viet L Bui; Arthur Mortha; Karin Oberle; Charlotte Heners; Caroline Johner; Andreas Diefenbach
Journal:  Nat Immunol       Date:  2008-11-23       Impact factor: 25.606

10.  The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells.

Authors:  Michel H Maillard; Vinicius Cotta-de-Almeida; Fuminao Takeshima; Deanna D Nguyen; Pierre Michetti; Cathryn Nagler; Atul K Bhan; Scott B Snapper
Journal:  J Exp Med       Date:  2007-02-12       Impact factor: 14.307

View more
  22 in total

Review 1.  Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.

Authors:  Mei Lan Chen; Mark S Sundrud
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

2.  Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+ CD45RB high T Cells into Immunodeficient Mice.

Authors:  Erin C Steinbach; Gregory R Gipson; Shehzad Z Sheikh
Journal:  J Vis Exp       Date:  2015-04-21       Impact factor: 1.355

3.  Alterations to chromatin in intestinal macrophages link IL-10 deficiency to inappropriate inflammatory responses.

Authors:  Jeremy M Simon; James P Davis; Saangyoung E Lee; Matthew R Schaner; Gregory R Gipson; Matthew Weiser; R Balfour Sartor; Hans H Herfarth; Reza Rahbar; Timothy S Sadiq; Mark J Koruda; Dermot P McGovern; Jason D Lieb; Karen L Mohlke; Terrence S Furey; Shehzad Z Sheikh
Journal:  Eur J Immunol       Date:  2016-06-01       Impact factor: 5.532

4.  Inhibition of Inflammatory Gene Transcription by IL-10 Is Associated with Rapid Suppression of Lipopolysaccharide-Induced Enhancer Activation.

Authors:  Evan A Conaway; Dalila C de Oliveira; Christine M McInnis; Scott B Snapper; Bruce H Horwitz
Journal:  J Immunol       Date:  2017-02-17       Impact factor: 5.422

5.  Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses.

Authors:  Mauricio F Farez; Ivan D Mascanfroni; Santiago P Méndez-Huergo; Ada Yeste; Gopal Murugaiyan; Lucien P Garo; María E Balbuena Aguirre; Bonny Patel; María C Ysrraelit; Chen Zhu; Vijay K Kuchroo; Gabriel A Rabinovich; Francisco J Quintana; Jorge Correale
Journal:  Cell       Date:  2015-09-10       Impact factor: 41.582

Review 6.  Innate lymphoid cells in the initiation, regulation and resolution of inflammation.

Authors:  Gregory F Sonnenberg; David Artis
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

Review 7.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

8.  A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease.

Authors:  Vivian Zhou; Kimberle Agle; Xiao Chen; Amy Beres; Richard Komorowski; Ludovic Belle; Carolyn Taylor; Fenlu Zhu; Dipica Haribhai; Calvin B Williams; James Verbsky; Wendy Blumenschein; Svetlana Sadekova; Eddie Bowman; Christie Ballantyne; Casey Weaver; David A Serody; Benjamin Vincent; Jonathan Serody; Daniel J Cua; William R Drobyski
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

9.  Restriction of Viral Replication, Rather than T Cell Immunopathology, Drives Lethality in Murine Norovirus CR6-Infected STAT1-Deficient Mice.

Authors:  Andrew J Sharon; Heather A Filyk; Nicolette M Fonseca; Rachel L Simister; Renata B Filler; Wallace Yuen; Blair K Hardman; Hannah G Robinson; Jung Hee Seo; Joana Rocha-Pereira; Ian Welch; Johan Neyts; Craig B Wilen; Sean A Crowe; Lisa C Osborne
Journal:  J Virol       Date:  2022-02-02       Impact factor: 6.549

10.  Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens.

Authors:  Theresa L Geiger; Michael C Abt; Georg Gasteiger; Matthew A Firth; Margaret H O'Connor; Clair D Geary; Timothy E O'Sullivan; Marcel R van den Brink; Eric G Pamer; Alan M Hanash; Joseph C Sun
Journal:  J Exp Med       Date:  2014-08-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.